WO2024095215 - METHOD FOR MAINTAINING QUIESCENCE OF EARLY STAGE DUPUYTREN'S DISEASE IN INDIVIDUALS ACHIEVING QUIESCENCE AFTER RECEIVING FOUR INJECTIONS OF ADALIMUMAB OVER TWELVE MONTHS
National phase entry:
Publication Number
WO/2024/095215
Publication Date
10.05.2024
International Application No.
PCT/IB2023/061090
International Filing Date
02.11.2023
Title **
[English]
METHOD FOR MAINTAINING QUIESCENCE OF EARLY STAGE DUPUYTREN'S DISEASE IN INDIVIDUALS ACHIEVING QUIESCENCE AFTER RECEIVING FOUR INJECTIONS OF ADALIMUMAB OVER TWELVE MONTHS
[French]
PROCÉDÉ DE MAINTIEN DE LA QUIESCENCE DE LA MALADIE DE DUPUYTREN AU STADE PRÉCOCE CHEZ DES INDIVIDUS ATTEIGNANT LA QUIESCENCE APRÈS RÉCEPTION DE QUATRE INJECTIONS D'ADALIMUMAB SUR DOUZE MOIS
Applicants **
OXFORD UNIVERSITY INNOVATION LIMITED
Inventors
NANCHAHAL, Jagdeep
DAKIN, Helen A.
Priority Data
63/382,196
03.11.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2379 | |
| EPO | Filing, Examination, Granting | 10234 | |
| Japan | Filing, Examination, Granting | 1914 | |
| South Korea | Filing, Examination, Granting | 1488 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,755
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
This invention provides a method for maintaining quiescence in an early stage Dupuytren's disease nodule on the hand of an individual who has achieved quiescence in such nodule after receiving four initial injections of a liquid pharmaceutical composition containing 40 mg of adalimumab into such nodule..[French]
La présente invention concerne un procédé de maintien de la quiescence dans un nodule associé à la maladie de Dupuytren au stade précoce sur la main d'un individu ayant atteint la quiescence dans un tel nodule après réception de quatre injections initiales d'une composition pharmaceutique liquide contenant 40 mg d'adalimumab dans un tel nodule.